Comment from the Board of Directors of Biokraft International AB (publ) about the mandatory tender offer from 1Vision Biogas
1Vision Biogas AB (“1Vision Biogas”) has today announced a mandatory cash tender offer for the shares in Biokraft International AB (publ), reg.no 556528-4733 (“Biokraft” or the “Company”) at a price of SEK 20.65 per share (the “Offer”).
The Offer is made due to 1Vision Biogas’ shareholding in Biokraft, following Aneo Renewables Holding AS and St1 Sverige AB consolidated their respective shareholding in Biokraft into the newly established and jointly owned company 1Vision Biogas, which now corresponds to approximately 55 per cent of the total number of shares and votes in the Company. 1Vision Biogas is therefore, in accordance with the Stock Market Self-Regulation Committee’s takeover rules for certain trading platforms (the “Takeover Rules”), obliged to make a mandatory tender offer for the remaining shares in Biokraft.
For further information regarding the Offer, please see 1Vision Biogas’ announcement of the Offer and offer document regarding the Offer, which are available on 1Vision Biogas’ website, www.1visionbiogas.se.
The acceptance period of the Offer commences on 5 February 2024 and expires on 11 March 2024.
The Board of Directors of Biokraft will now evaluate the Offer and obtain a valuation opinion. The Board of Directors will no later than two weeks prior to the expiry of the acceptance period announce its opinion of the Offer, including the reasons for its opinion. The board members Jan Helland Eide and Håkon Welde have not, and will not, due to a conflict of interest, participate in the Board of Directors’ processing of or resolutions on matters related to the Offer.
This information was submitted, through the care of the agency of the contact person, for publication on 2 February 2024 at 15:40 CET.
For more information, please contact:
Matti Vikkula, CEO Biokraft International AB
Telephone +46-70 597 99 38
Email: matti.vikkula(at)biokraft.com
Biokraft is a Nordic greentech company that produces bioenergy and plant nutrition in a circular cycle by recycling organic waste and residual products in large-scale biorefineries. Biogas is CO2-neutral and lowers GHG emissions by over 100% when replacing fossil fuels. Biokraft will build, own and operate large-scale biogas plants with a focus on the Northern European market. Today there are facilities in Sweden, Norway and Korea. Biokraft has just over 110 employees and had total revenues of SEK 407 million in 2022. The company is listed on the Nasdaq First North Premier Growth Market. The Certified Adviser is Carnegie Investment Bank AB (publ). www.biokraft.com